Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dimethylhydrazine | increases expression | ISO | Shisa5 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of SHISA5 mRNA | CTD | PMID:22206623 | 1,2-dimethylhydrazine | multiple interactions | ISO | Shisa5 (Mus musculus) | 6480464 | Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in increased expression of SHISA5 mRNA] | CTD | PMID:22206623 | 17alpha-ethynylestradiol | affects expression | ISO | Shisa5 (Mus musculus) | 6480464 | Ethinyl Estradiol affects the expression of SHISA5 mRNA | CTD | PMID:17555576 | 17beta-estradiol | increases expression | ISO | Shisa5 (Mus musculus) | 6480464 | Estradiol results in increased expression of SHISA5 mRNA | CTD | PMID:15289156 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Shisa5 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of SHISA5 mRNA | CTD | PMID:21570461 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of SHISA5 mRNA | CTD | PMID:34747641 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Shisa5 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SHISA5 mRNA | CTD | PMID:15034205 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | SHISA5 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin affects the expression of SHISA5 mRNA | CTD | PMID:22574217 | 2-butoxyethanol | decreases expression | ISO | Shisa5 (Mus musculus) | 6480464 | n-butoxyethanol results in decreased expression of SHISA5 mRNA | CTD | PMID:19812364 | acetamide | increases expression | EXP | | 6480464 | acetamide results in increased expression of SHISA5 mRNA | CTD | PMID:31881176 | acrylamide | increases expression | EXP | | 6480464 | Acrylamide results in increased expression of SHISA5 mRNA | CTD | PMID:28959563 | acrylamide | increases expression | ISO | Shisa5 (Mus musculus) | 6480464 | Acrylamide results in increased expression of SHISA5 mRNA | CTD | PMID:30807115 | all-trans-retinoic acid | increases expression | ISO | SHISA5 (Homo sapiens) | 6480464 | Tretinoin results in increased expression of SHISA5 mRNA | CTD | PMID:33167477 | aluminium atom | decreases expression | ISO | Shisa5 (Mus musculus) | 6480464 | Aluminum results in decreased expression of SHISA5 mRNA | CTD | PMID:37544489 | aluminium(0) | decreases expression | ISO | Shisa5 (Mus musculus) | 6480464 | Aluminum results in decreased expression of SHISA5 mRNA | CTD | PMID:37544489 | atrazine | increases expression | ISO | SHISA5 (Homo sapiens) | 6480464 | Atrazine results in increased expression of SHISA5 mRNA | CTD | PMID:22378314 | benzo[a]pyrene | increases expression | ISO | Shisa5 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of SHISA5 mRNA | CTD | PMID:15034205 | bisphenol A | increases expression | ISO | SHISA5 (Homo sapiens) | 6480464 | bisphenol A results in increased expression of SHISA5 mRNA | CTD | PMID:25047013 | bisphenol A | decreases expression | ISO | Shisa5 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of SHISA5 mRNA | CTD | PMID:35598803 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of SHISA5 mRNA | CTD | PMID:34947998 | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of SHISA5 gene | CTD | PMID:28505145 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of SHISA5 mRNA | CTD | PMID:25181051 | cadmium atom | multiple interactions | ISO | SHISA5 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SHISA5 mRNA | CTD | PMID:35301059 | cadmium dichloride | multiple interactions | ISO | SHISA5 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SHISA5 mRNA | CTD | PMID:35301059 | carbon nanotube | decreases expression | ISO | Shisa5 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25620056 | carbon nanotube | increases expression | ISO | Shisa5 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | chloropicrin | increases expression | ISO | SHISA5 (Homo sapiens) | 6480464 | chloropicrin results in increased expression of SHISA5 mRNA | CTD | PMID:26352163 | cholesterol | multiple interactions | ISO | Shisa5 (Mus musculus) | 6480464 | [Cholesterol co-treated with 1 and 2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of SHISA5 mRNA | CTD | PMID:22129739 | cisplatin | increases expression | ISO | Shisa5 (Mus musculus) | 6480464 | Cisplatin results in increased expression of SHISA5 mRNA | CTD | PMID:21151649 | clofibrate | multiple interactions | ISO | Shisa5 (Mus musculus) | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of SHISA5 mRNA and PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of SHISA5 mRNA] | CTD | PMID:17585979 | clofibrate | decreases expression | ISO | Shisa5 (Mus musculus) | 6480464 | Clofibrate results in decreased expression of SHISA5 mRNA | CTD | PMID:17585979 | copper atom | multiple interactions | ISO | SHISA5 (Homo sapiens) | 6480464 | [Chelating Agents binds to Copper] which results in decreased expression of SHISA5 mRNA | CTD | PMID:30911355 | copper(0) | multiple interactions | ISO | SHISA5 (Homo sapiens) | 6480464 | [Chelating Agents binds to Copper] which results in decreased expression of SHISA5 mRNA | CTD | PMID:30911355 | copper(II) sulfate | decreases expression | ISO | SHISA5 (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of SHISA5 mRNA | CTD | PMID:19549813 | cyclosporin A | decreases expression | ISO | SHISA5 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of SHISA5 mRNA | CTD | PMID:20106945 | cyclosporin A | increases expression | ISO | Shisa5 (Mus musculus) | 6480464 | Cyclosporine results in increased expression of SHISA5 mRNA | CTD | PMID:19770486 | diazinon | increases methylation | ISO | SHISA5 (Homo sapiens) | 6480464 | Diazinon results in increased methylation of SHISA5 gene | CTD | PMID:22964155 | dibutyl phthalate | increases expression | EXP | | 6480464 | Dibutyl Phthalate results in increased expression of SHISA5 mRNA | CTD | PMID:21266533 | diethylstilbestrol | increases expression | ISO | Shisa5 (Mus musculus) | 6480464 | Diethylstilbestrol results in increased expression of SHISA5 mRNA | CTD | PMID:15289156 | epoxiconazole | decreases expression | ISO | Shisa5 (Mus musculus) | 6480464 | epoxiconazole results in decreased expression of SHISA5 mRNA | CTD | PMID:35436446 | ethanol | affects expression | ISO | Shisa5 (Mus musculus) | 6480464 | Ethanol affects the expression of SHISA5 mRNA | CTD | PMID:30319688 | folic acid | multiple interactions | ISO | Shisa5 (Mus musculus) | 6480464 | Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in increased expression of SHISA5 mRNA] | CTD | PMID:22206623 | genistein | increases expression | ISO | Shisa5 (Mus musculus) | 6480464 | Genistein results in increased expression of SHISA5 mRNA | CTD | PMID:15289156 | oxaliplatin | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in increased expression of SHISA5 mRNA | CTD | PMID:25729387 | paracetamol | multiple interactions | ISO | Shisa5 (Mus musculus) | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of SHISA5 mRNA and PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of SHISA5 mRNA] | CTD | PMID:17585979 | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of SHISA5 mRNA | CTD | PMID:33387578 | paracetamol | decreases expression | ISO | SHISA5 (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of SHISA5 mRNA | CTD | PMID:21420995 | paracetamol | affects expression | ISO | Shisa5 (Mus musculus) | 6480464 | Acetaminophen affects the expression of SHISA5 mRNA | CTD | PMID:17562736 | pentachlorophenol | increases expression | ISO | Shisa5 (Mus musculus) | 6480464 | Pentachlorophenol results in increased expression of SHISA5 mRNA | CTD | PMID:23892564 | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Shisa5 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of SHISA5 mRNA | CTD | PMID:36331819 | pinostrobin | increases expression | ISO | SHISA5 (Homo sapiens) | 6480464 | pinostrobin results in increased expression of SHISA5 mRNA | CTD | PMID:37777166 | silver atom | decreases expression | ISO | Shisa5 (Mus musculus) | 6480464 | Silver results in decreased expression of SHISA5 mRNA | CTD | PMID:27131904 | silver(0) | decreases expression | ISO | Shisa5 (Mus musculus) | 6480464 | Silver results in decreased expression of SHISA5 mRNA | CTD | PMID:27131904 | sodium arsenite | increases expression | ISO | Shisa5 (Mus musculus) | 6480464 | sodium arsenite results in increased expression of SHISA5 mRNA | CTD | PMID:20477944 | Soman | increases expression | EXP | | 6480464 | Soman results in increased expression of SHISA5 mRNA | CTD | PMID:19281266 | sunitinib | decreases expression | ISO | SHISA5 (Homo sapiens) | 6480464 | Sunitinib results in decreased expression of SHISA5 mRNA | CTD | PMID:31533062 | tamoxifen | affects expression | ISO | Shisa5 (Mus musculus) | 6480464 | Tamoxifen affects the expression of SHISA5 mRNA | CTD | PMID:17555576 and PMID:20937368 | temozolomide | increases expression | ISO | SHISA5 (Homo sapiens) | 6480464 | Temozolomide results in increased expression of SHISA5 mRNA | CTD | PMID:31758290 | tert-butyl hydroperoxide | increases expression | ISO | Shisa5 (Mus musculus) | 6480464 | tert-Butylhydroperoxide results in increased expression of SHISA5 mRNA | CTD | PMID:14729362 and PMID:15003993 | tetrachloromethane | affects expression | ISO | Shisa5 (Mus musculus) | 6480464 | Carbon Tetrachloride affects the expression of SHISA5 mRNA | CTD | PMID:17484886 | tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of SHISA5 mRNA | CTD | PMID:31150632 | thimerosal | decreases expression | ISO | SHISA5 (Homo sapiens) | 6480464 | Thimerosal results in decreased expression of SHISA5 mRNA | CTD | PMID:27188386 | topotecan | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in increased expression of SHISA5 mRNA | CTD | PMID:25729387 | triptonide | affects expression | ISO | Shisa5 (Mus musculus) | 6480464 | triptonide affects the expression of SHISA5 mRNA | CTD | PMID:33045310 | troglitazone | decreases expression | ISO | Shisa5 (Mus musculus) | 6480464 | troglitazone results in decreased expression of SHISA5 mRNA | CTD | PMID:17569031 | valproic acid | decreases expression | ISO | SHISA5 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of SHISA5 mRNA | CTD | PMID:29154799 | vorinostat | decreases expression | ISO | SHISA5 (Homo sapiens) | 6480464 | vorinostat results in decreased expression of SHISA5 mRNA | CTD | PMID:27188386 | |